Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paula Gomez-Marzo"'
Autor:
Blanca Xicoy, Nuri de Haro, Francisco Fuster-Tormo, Paula Gomez-Marzo, Mar Mallo, Maria Pilar Armengol, Laura Palomo, Lurdes Zamora, Francesc Solé, Daniel Alvira, Vera Adema
Publikováno v:
Biopreservation and Biobanking. 15:360-365
Whole genome amplification (WGA) has become an invaluable method for preserving limited samples of precious stock material and has been used during the past years as an alternative tool to increase the amount of DNA before library preparation for nex
Autor:
Christina Ganster, Martin Stromburg, N. De Haro, F. Solé, Laura Palomo, Blanca Xicoy, Francisco Fuster-Tormo, Mar Mallo, D. Haase, Lurdes Zamora, Lorenz Truemper, F. Jiménez-García, Alina Brockmann, Sascha Dierks, Arkadiusz Kominowski, Paula Gomez-Marzo, Pamela Acha, Neus Solanes, Roman Martin, Vera Adema
Publikováno v:
Leukemia Research. 55:S154
Autor:
Blanca Xicoy, Mar Mallo, Roman Martin, Lurdes Zamora, Martin Stromburg, Lorenz Truemper, Vera Adema, Sascha Dierks, Paula Gomez-Marzo, Pamela Acha, Francisco Fuster-Tormo, Neus Solanes, Christina Ganster, Francesc Solé, Arkadiusz Kominowski, Nuria de Haro, Alina Brockmann, Laura Palomo, Detlef Haase
Publikováno v:
ResearcherID
Myelodysplastic syndromes (MDS) are clonal stem cell diseases of the bone marrow (BM) characterized by a dysfunction of hematopoiesis commonly resulting in cytopenias, dysplasia and an increased risk of acute myeloid leukemia (AML) development. In up
Autor:
Blanca Xicoy, Beatriz Arrizabalaga Amunchastegui, Paula Gomez-Marzo, Francisco Fuster-Tormo, Jesús María Hernández-Rivas, Nuri de Haro, Francesc Solé, Pierre Fenaux, Valeria Visconte, Esperanza Such, Juan C. Cigudosa, María José Larrayoz, Mar Mallo, Lurdes Zamora, Michaela Fontenay, Alexander Neef, Laura Palomo, Kamila Janusz, Paolo Maietta, Mónica del Rey, Jaroslaw P. Maciejewski, Rocío Benito, Olivier Kosmider, José Cervera, María José Calasanz, Rocío Salgado, Mariam Ibáñez, Vera Adema
Publikováno v:
Blood. 128:3172-3172
Background: Lenalidomide (LEN) is an immunomodulatory drug which binds cereblon through a glutarimide ring modulating the substrate specificity of CRL4CRBNE3 ubiquitin ligase complex, resulting in the proteosomal degradation of specific disease-relat
Autor:
Maria Pilar Armengol, Nuri de Haro, Francisco Fuster-Tormo, Daniel Alvira, Blanca Xicoy, Paula Gomez-Marzo, Lurdes Zamora, Vera Adema, Mar Mallo, Laura Palomo, Francesc Solé
Publikováno v:
Blood. 128:5519-5519
Background: Whole genome amplification (WGA) has become an invaluable method for working with small amounts of starting DNA and for preserving limited samples of precious stock material. Next-Generation Sequencing (NGS) techniques can benefit from WG
Autor:
Olga García, Elisa Luño, Alberto Valiente, Jaime Pérez-Oteyza, Jesús María Hernández-Rivas, Rosa Collado, Xabier Aguirre, Leonor Arenillas, Francesc Solé, Sara Alvarez, Paula Gomez-Marzo, Eva Lumbreras, Mar Mallo, Teresa Vallespi, Vera Adema, Ismael Buño, Laura Palomo, Carolina Martínez-Laperche, Calasanz Maria Jose, Beatriz Blazquez, Larrayoz Maria Jose, Ana Vicente, José Cervera, Ana Patiño-García
Publikováno v:
ResearcherID
Web of Science
Web of Science
INTRODUCTION Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal myeloid stem cell disorders highly prevalent in elderly populations. MDS are characterized by inefficient hematopoiesis, peripheral blood (PB) cytopenias, and increased
Autor:
María Consuelo del Cañizo, Albert Perez-Ladaga, Vera Adema, Joaquin Sanchez-Garcia, Carmen Sanzo, Mònica Bayés, Blanca Xicoy, Francesc Solé, Eduardo Rios, Rosario López, Rafael Bejar, Elisa Luño, Mar Mallo, Lurdes Zamora, Carmen Pedro, María Díez-Campelo, Leonor Arenillas, Paula Gomez-Marzo, Montserrat Arnan, Shawn Yost, Ivo Gut, Laura Palomo, Raquel de Paz, Angelina Lemes, Lourdes Florensa, José María Raya
Publikováno v:
Blood. 124:4635-4635
INTRODUCTION Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal myeloid stem cell disorders that are highly prevalent in elderly populations. MDS are characterized by inefficient hematopoiesis, peripheral blood (PB) cytopenias, and i